Annual Drug Patent Expirations for FINTEPLA
Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug.
The generic ingredient in FINTEPLA is fenfluramine hydrochloride. One supplier is listed for this compound. Additional details are available on the fenfluramine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
